FDA Issues Two Guidances For PrEP And Pediatric HIV Drug Development.

BioCentury (3/19, Romeo, Subscription Publication) reports the “FDA released final versions of two guidances Tuesday aimed at developing drugs for pediatric HIV patients and for pre-exposure prophylaxis (PrEP), which HHS Secretary Alex Azar said was in li...